Quest Diagnostics (DGX) announced that Adrienne Brott has been named senior vice president and chief quality and regulatory affairs officer.

Leerink upgraded Quest Diagnostics (DGX) to Outperform from Market Perform with a price target of $174, up from $169. The firm notes its view ...

Shares of Quest Diagnostics Inc. DGX shed 1.45% to $151.79 Friday, on what proved to be an all-around dismal trading session ...

Shares of Quest Diagnostics Inc. DGX inched 0.23% higher to $152.27 Monday, on what proved to be an all-around mixed trading ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that Adrienne L. Brott, ...

OhioHealth Corp. has outsourced some lab work to Quest Diagnostics Inc., part of a growing healthcare trend. Quest (NYSE:DGX) ...

Quest Diagnostics Inc.’s DGX continued momentum in the base business is poised to help it grow in the upcoming quarters. The ongoing adoption of the highly specialized Advanced Diagnostics ...

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group focused ...

According to Benzinga Pro, Quest Diagnostics's peer group average for short interest as a percentage of float is 8.62%, which ...